Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2660 of 3330
Next
>>
>
66476 to 66500 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	5912.069	0.9546	0.9053	0.9582
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	5912.069	0.9461	0.8877	0.9582
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	5912.069	0.8453	0.6782	0.9582
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	5912.069	0.7192	0.4178	0.9582
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	5912.069	0.6170	0.2082	0.9582
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	5912.069	0.6252	0.2250	0.9582
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	5912.069	0.5442	0.0599	0.9582
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	5912.069	0.5087	-0.0122	0.9582
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	7805.068	0.9830	0.9607	0.8633
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	7805.068	0.8777	0.7195	0.8633
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	7805.068	0.7669	0.4707	0.8633
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	7805.068	0.6374	0.1871	0.8633
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	7805.068	0.5683	0.0393	0.8633
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	7805.068	0.5872	0.0794	0.8633
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	7805.068	0.6011	0.1092	0.8633
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	7805.068	0.6144	0.1375	0.8633
CAMA-1	HR+	Luminal	Sirolimus	MTOR	MTOR	167	uM	7805.068	0.4483	-0.2105	0.8633
HBL-100	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.000427	uM	7429.068	0.9954	0.9960	2.2830
HBL-100	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.00213	uM	7429.068	0.9606	0.9651	2.2830
HBL-100	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.0107	uM	7429.068	0.8756	0.8869	2.2830
HBL-100	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.0533	uM	7429.068	0.8303	0.8436	2.2830
HBL-100	Unknown	Unknown	Sirolimus	MTOR	MTOR	0.267	uM	7429.068	0.7635	0.7771	2.2830
HBL-100	Unknown	Unknown	Sirolimus	MTOR	MTOR	1.33	uM	7429.068	0.7859	0.7997	2.2830
HBL-100	Unknown	Unknown	Sirolimus	MTOR	MTOR	6.67	uM	7429.068	0.7915	0.8053	2.2830
HBL-100	Unknown	Unknown	Sirolimus	MTOR	MTOR	33.3	uM	7429.068	0.6864	0.6961	2.2830

|<
<<
Previous
Page 2660 of 3330
Next
>>
>
66476 to 66500 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)